Related references
Note: Only part of the references are listed.Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma
Wei Ju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Current complexity: a tool for assessing the complexity of organic molecules
Jun Li et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
Bryan T. Mott et al.
SCIENTIFIC REPORTS (2015)
What is synergy? The Saariselka agreement revisited
Jing Tang et al.
FRONTIERS IN PHARMACOLOGY (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
adabag: AnRPackage for Classification with Boosting and Bagging
Esteban Alfaro et al.
Journal of Statistical Software (2015)
Modeling a Crowdsourced Definition of Molecular Complexity
Robert P. Sheridan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
A Comparison of MCC and CEN Error Measures in Multi-Class Prediction
Giuseppe Jurman et al.
PLOS ONE (2012)
Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery
Peter S. Kutchukian et al.
PLOS ONE (2012)
Library Enhancement through the Wisdom of Crowds
Michael D. Hack et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Systematic exploration of synergistic drug pairs
Murat Cokol et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
A crowdsourcing evaluation of the NIH chemical probes
Tudor I. Oprea et al.
NATURE CHEMICAL BIOLOGY (2009)
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species:: Analysis by a new response surface model
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays
Xiaohua Douglas Zhang
GENOMICS (2007)
The minimum significant ratio: A statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies
BJ Eastwood et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Statistical practice in high-throughput screening data analysis
N Malo et al.
NATURE BIOTECHNOLOGY (2006)
Assessment of the consistency of medicinal chemists in reviewing sets of compounds
MS Lajiness et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Nonmonotonic dose-response relationships: Mechanistic basis, kinetic modeling, and implications for risk assessment
RB Conolly et al.
TOXICOLOGICAL SCIENCES (2004)
Statistical and graphical methods for quality control determination of high-throughput screening data
B Gunter et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
A simple technique for reducing edge effect in cell-based assays
BK Lundholt et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Systematic discovery of multicomponent therapeutics
AA Borisy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)